11/5/2014, Pain Experts Say New Opioid Has ‘Enormous’ Potential
“There’s a great opportunity for drugs like that. We really need to find something that doesn’t have rewarding properties that doesn’t lead to addiction,” said Lynn Webster, MD, past president of the American Academy of Pain Medicine, who was the lead investigator in initial studies of the drug.
10/29/2014, Cara’s pain drug clears an abuse hurdle as it trots toward Phase III
12/13/2012, Is The Era Of OxyContin Abuse Over?
“I can’t understand it, says Dr. Lynn Webster, the incoming president of the American Academy of Pain Medicine, and author of “Avoiding Opioid Abuse While Managing Pain: A Guide for Practitioners, “Canada has just taken a very dangerous step.” He believes, by contrast, that in the US, the Food and Drug Administration should “only approve drugs with abuse resistant properties.”